• All Share : 54440.4294
    DOWN -0.19%
    Top40 - (Tradeable) : 48195.4806
    DOWN -0.21%
    Financial 15 : 17791.5587
    UP 0.74%
    Industrial 25 : 68352.8532
    DOWN -0.20%
    Resource 10 : 44235.4175
    DOWN -1.28%

  • ZAR/USD : 12.0658
    UP 1.42%
    ZAR/GBP : 18.2278
    UP 0.61%
    ZAR/EUR : 13.5061
    UP 0.89%
    ZAR/JPY : 0.0999
    UP 1.11%
    ZAR/AUD : 9.4607
    UP 1.04%

  • Gold US$/oz : 1179.63
    UNCHANGED0.00%
    Platinum US$/oz : 1136.25
    UNCHANGED0.00%
    Silver US$/oz : 16.12
    UNCHANGED0.00%
    Palladium US$/oz : 775.75
    UNCHANGED0.00%
    Brent Crude : 66.33
    UNCHANGED0.00%

  • All data is delayed by 15 min. Data supplied by Profile Data
    Hover cursor over this ticker to pause.

Send Mail

Melanoma drug nearly doubles survival time: study

A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said.

AFP Relaxnews

 24 February, 2012 10:45
* Required